期刊文献+
共找到1,401篇文章
< 1 2 71 >
每页显示 20 50 100
骨疏康干预破骨细胞:激活核因子E2相关因子2调控c-Fos/NFATc1通路
1
作者 侯成志 韩佳童 +4 位作者 魏光成 卓泽川 李秋月 赵勇 俞张镜泽 《中国组织工程研究》 CAS 北大核心 2025年第2期279-285,共7页
背景:已有研究表明,骨疏康通过调节核苷酸、氨基酸代谢和免疫机制影响骨骼代谢,目前骨疏康治疗骨质疏松症的机制研究主要聚焦于调控成骨细胞,对破骨细胞的关注较少。目的:以RAW 264.7细胞为实验对象,从破骨细胞角度探讨骨疏康治疗骨质... 背景:已有研究表明,骨疏康通过调节核苷酸、氨基酸代谢和免疫机制影响骨骼代谢,目前骨疏康治疗骨质疏松症的机制研究主要聚焦于调控成骨细胞,对破骨细胞的关注较少。目的:以RAW 264.7细胞为实验对象,从破骨细胞角度探讨骨疏康治疗骨质疏松症的机制。方法:取8周龄雌性SD大鼠24只,采用随机数字表法分为4组(n=6),3个实验组分别灌胃给予1,2,4 g/kg的骨疏康药液(2次/d),对照组灌胃给予等量蒸馏水(2次/d),连续灌胃7 d后抽取大鼠主动脉血,离心收集血清,同组血清合并,获得低、中、高浓度的骨疏康含药血清及正常血清,进行后续实验。①将RAW 264.7细胞分6组培养:对照组加入正常血清,低、中、高浓度组分别加入低、中、高浓度的骨疏康含药血清,Nrf2抑制剂组加入核因子E2相关因子2(nuclear factor erythroid 2-related factor 2,Nrf2)抑制剂ML385,Nrf2激活剂组加入Nrf2激活剂t-BHQ,采用CCK8法检测细胞相对活性。②将第3代RAW 264.7细胞分5组培养:空白对照组加入正常血清,破骨组加入核因子κB受体活化因子配体(receptor activator of nuclear factorκB ligand,RANKL),低、中、高浓度组在加入RANKL的基础上分别加入低、中、高浓度的骨疏康含药血清,培养5 d后进行抗酒石酸酸性磷酸染色。③将RAW 264.7细胞分5组培养:空白对照组加入正常血清,破骨组加入正常血清与RANKL,高浓度+破骨组加入RANKL+高浓度骨疏康含药血清,破骨+Nrf2激动剂组加入RANKL+t-BHQ,高浓度+破骨+Nrf2抑制剂组加入RANKL+高浓度骨疏康含药血清+ML385,培养5 d后进行Western Blot与活性氧含量检测。结果与结论:①CCK8检测结果显示,骨疏康含药血清及Nrf2抑制剂、激动剂对RAW 264.7细胞活力无明显影响;②抗酒石酸酸性磷酸染色结果显示,骨疏康含药血清呈浓度依赖性抑制破骨细胞的分化;③Western Blot与活性氧含量检测结果显示,与空白对照组比较,破骨组Nrf2蛋白表达降低(P<0.05),c-Fos、NFATc1蛋白表达与活性氧含量升高(P<0.05);与破骨组比较,高浓度+破骨组、破骨+Nrf2激动剂组、高浓度+破骨+Nrf2抑制剂组Nrf2蛋白表达升高、活性氧含量降低(P<0.05),高浓度+破骨组、破骨+Nrf2激动剂组c-Fos、NFATc1蛋白表达降低(P<0.05);与高浓度+破骨组比较,高浓度+破骨+Nrf2抑制剂组Nrf2蛋白表达降低(P<0.05),活性氧含量升高(P<0.05);④结果表明,骨疏康通过激活Nrf2减少活性氧生成,进而抑制下游c-Fos/NFATc1通路表达和破骨细胞分化。 展开更多
关键词 骨质疏松症 骨疏康 含药血清 破骨细胞 Nrf2 c-Fos/NFATc1通路 RAW 264.7细胞
下载PDF
Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis
2
作者 Ren-Qi Mu Jun-Wei Lv +3 位作者 Cai-Yun Ma Xiao-Hui Ma Dong Xing Hou-Sheng Ma 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第5期1796-1807,共12页
BACKGROUND Rectal carcinoma(RC),one of the most common malignancies globally,presents an increasing incidence and mortality year by year,especially among young people,which seriously affects the prognosis and quality ... BACKGROUND Rectal carcinoma(RC),one of the most common malignancies globally,presents an increasing incidence and mortality year by year,especially among young people,which seriously affects the prognosis and quality of life of patients.At present,dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)parameters and serum carbohydrate antigen 19-9(CA19-9)and CA125 Levels have been used in clinical practice to evaluate the T stage and differentiation of RC.However,the accuracy of these evaluation modalities still needs further research.This study explores the application and value of these methods in evaluating the T stage and differentiation degree of RC.AIM To analyze the diagnostic performance of DCE-MRI parameters combined with serum tumor markers(TMs)in assessing pathological processes and prognosis of RC patients.METHODS A retrospective analysis was performed on 104 RC patients treated at Yantai Yuhuangding Hospital from May 2018 to January 2022.Patients were categorized into stages T1,T2,T3,and T4,depending on their T stage and differentiation degree.In addition,they were assigned to low(L group)and moderate-high differentiation(M+H group)groups based on their differentiation degree.The levels of DCE-MRI parameters and serum CA19-9 and CA125 in different groups of patients were compared.In addition,the value of DCE-MRI parameters[volume transfer constant(Ktrans),rate constant(Kep),and extravascular extracellular volume fraction(Ve)in assessing the differentiation and T staging of RC patients was discussed.Furthermore,the usefulness of DCE-MRI parameters combined with serum CA19-9 and CA125 Levels in the evaluation of RC differentiation and T staging was analyzed.RESULTS Ktrans,Ve,CA19-9 and CA125 were higher in the high-stage group and L group than in the low-stage group and M+H Group,respectively(P<0.05).The areas under the curve(AUCs)of the Ktran and Ve parameters were 0.638 and 0.694 in the diagnosis of high and low stages,respectively,and 0.672 and 0.725 in diagnosing moderate-high and low differentiation,respectively.The AUC of DCE-MRI parameters(Ktrans+Ve)in the diagnosis of high and low stages was 0.742,and the AUC in diagnosing moderate-high and low differentiation was 0.769.The AUCs of CA19-9 and CA-125 were 0.773 and 0.802 in the diagnosis of high and low stages,respectively,and 0.834 and 0.796 in diagnosing moderate-high and low differentiation,respectively.Then,we combined DCE-MRI(Ktrans+Ve)parameters with CA19-9 and CA-125 and found that the AUC of DCE-MRI parameters plus serum TMs was 0.836 in the diagnosis of high and low stages and 0.946 in the diagnosis of moderate-high and low differentiation.According to the Delong test,the AUC of DCE-MRI parameters plus serum TMs increased significantly compared with serum TMs alone in the diagnosis of T stage and differentiation degree(P<0.001).CONCLUSION The levels of the DCE-MRI parameters Ktrans and Ve and the serum TMs CA19-9 and CA125 all increase with increasing T stage and decreasing differentiation degree of RC and can be used as indices to evaluate the differentiation degree of RC in clinical practice.Moreover,the combined evaluation of the above indices has a better effect and more obvious clinical value,providing important guiding importance for clinical condition judgment and treatment selection. 展开更多
关键词 Rectal carcinoma Volume transfer constant Rate constant Extravascular extracellular volume fraction serum carbohydrate antigen 19-9 serum carbohydrate antigen 125
下载PDF
Serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4, carbohydrate antigen 24-2, ferritin) and gastric cancer prognosis correlation
3
作者 Jie-Wen Zhu Ling-Zhen Gong Qian-Wen Wang 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第9期2808-2814,共7页
BACKGROUND Gastric cancer is a kind of malignant tumor which is prevalent all over the world.Although some progress has been made in the treatment of gastric cancer,its prognosis is still not optimistic,so it is of gr... BACKGROUND Gastric cancer is a kind of malignant tumor which is prevalent all over the world.Although some progress has been made in the treatment of gastric cancer,its prognosis is still not optimistic,so it is of great significance to find reliable prog-nostic indicators to guide the treatment and management of patients with gastric cancer.AIM To explore the relationship between serum levels of five biomarkers[carcinoem-bryonic antigen(CEA),carbohydrate antigen(CA)19-9,CA72-4,CA24-2,and ferritin]and prognosis in patients with gastric cancer.METHODS This study included 200 patients with gastric adenocarcinoma,and conducted an in-depth analysis of their baseline characteristics,relationship between tumor markers and staging,and prognosis.The study found that CA19-9 has a signi-ficant correlation with tumor stage,the average levels of CA24-2,CEA,CA72-4 and ferritin were slightly increased disregarding the stage of tumor.Survival analysis showed that increases in CEA,CA19-9,CA24-2,and ferritin were all associated with shortened overall survival of patients.Further multivariate ana-lysis revealed that elevated serum CA72-4 levels were an inde-pendent adverse prognostic factor.RESULTS This study reveals that there is a significant correlation between the expression levels of serum tumor markers CEA,CA19-9,CA72-4,CA24-2 and ferritin in patients with gastric cancer and prognosis,and can be used as important indicators for prognostic evaluation of gastric cancer.In particular,markers that appear abnormally elevated initially may help identify gastric cancer patients with poor prognosis.CONCLUSION Serum CEA and CA19-9 play an important role in the prognosis assessment of gastric cancer,and are effective tools to guide clinical practice and optimize individualized treatment strategies for gastric cancer patients. 展开更多
关键词 Gastric cancer PROGNOSIS Carcinoembryonic antigen Carbohydrate antigen 19-9 Carbohydrate antigen 72-4 Carbohydrate antigen 24-2 FERRITIN serum markers Retrospective study
下载PDF
Analysis of Detecting HIV-1 Antibody in Paired Urine and Serum Specimens from Drug Users by ELISA
4
作者 刘中夫 李志军 +3 位作者 刘世亮 李莉 梁富雄 郑锡文 《Chinese Journal of Sexually Transmitted Infections》 2001年第2期27-28,共2页
Objective- To compare the consistency of the results from detecting HIV-1 antibody in the paired urine and serum specimens from drug users by ELISA. Methods: The paired urine and serum specimens from 273 drug users de... Objective- To compare the consistency of the results from detecting HIV-1 antibody in the paired urine and serum specimens from drug users by ELISA. Methods: The paired urine and serum specimens from 273 drug users detained at a detoxification unit were collected, and the HIV-1 antibodies in the specimens of them were screened by urine and serum ELISA kits, respectively. Results: Of 273 serum specimens, 94 ones showed positive reaction and among 94 counterpart urine specimens, 93 ones also appeared positive reaction. Taking the results together,the consistent rate of HIV-1 antibody screened by urine and serum ELISA kits was 99.6%. Conclusion: The urine ELISA kit, which screened HIV-1 antibody of urine showing almost the same results tested by serum ELISA kit, is reliable. It is proposed that urine ELISA be introduced in many fields. 展开更多
关键词 AIDS drug user Urine specimens serum specimens HIV-1 antibody
下载PDF
负载EPZ6438牛血清白蛋白-壳聚糖纳米粒抑制骨肉瘤的效应
5
作者 刘畅 张文 +3 位作者 朱灿 孙杰 丁亦程 施勤 《中国组织工程研究》 CAS 北大核心 2024年第10期1512-1518,共7页
背景:骨肉瘤肿瘤干细胞激活最显著的转录因子是EZH2,据报道沉默EZH2可以抑制骨肉瘤细胞生长。研究证实,牛血清白蛋白-壳聚糖纳米粒是一种具有优异生物相容性和生物降解性的药物传递载体,且白蛋白载体可提供靶向肿瘤的药物递送功能。目的... 背景:骨肉瘤肿瘤干细胞激活最显著的转录因子是EZH2,据报道沉默EZH2可以抑制骨肉瘤细胞生长。研究证实,牛血清白蛋白-壳聚糖纳米粒是一种具有优异生物相容性和生物降解性的药物传递载体,且白蛋白载体可提供靶向肿瘤的药物递送功能。目的:探讨负载EPZ6438(EZH2抑制剂)血清白蛋白-壳聚糖纳米粒抑制骨肉瘤的效应及机制。方法:①制备未负载与负载EPZ6438的血清白蛋白-壳聚糖纳米粒,检测载EPZ6438血清白蛋白-壳聚糖纳米粒的药物包载率及药物释放率。②将MG-63细胞分4组培养,分别加入PBS(对照组)、血清白蛋白-壳聚糖纳米粒浸提液(空白纳米粒组)、EPZ6438溶液(游离药物组)及负载EPZ6438的血清白蛋白-壳聚糖纳米粒浸提液(载药纳米粒组),培养3 d后,利用流式细胞仪检测细胞凋亡、RT-PCR法检测细胞caspase3 mRNA的表达。③取12只裸鼠,通过腋下注射MG-63细胞悬液建立皮下荷瘤小鼠模型,造模成功后随机分4组干预,分别向肿瘤组织内注射生理盐水(对照组)、血清白蛋白-壳聚糖纳米粒溶液(空白纳米粒组)、EPZ6438溶液(游离药物组)及负载EPZ6438的血清白蛋白-壳聚糖纳米粒溶液(载药纳米粒组),每组3只。注射7 d后,观察肿瘤体积及肿瘤组织冰冻切片TUNEL染色。结果与结论:①载药纳米粒的药物包载率约为8.8%,该纳米粒在纯水中具有良好的药物释放效果,24 h药物释放量为(34.72±1.93)μg,72 h为(48.58±1.10)μg,120 h为(49.18±1.24)μg,168 h(50.25±1.13)μg,药物释放在120 h到达平台期,释放率约为97.9%;②与MG-63细胞培养3 d后,对照组、空白纳米粒组细胞凋亡率低于游离药物组、载药纳米粒组(P<0.001),caspase3 mRNA的表达低于游离药物组、载药纳米粒组(P<0.0001);③注射7 d后,载药纳米粒组裸鼠肿瘤体积小其他3组(P<0.05),肿瘤组织TUNEL染色阳性细胞比率高于其他3组(P<0.0001);④结果显示,负载EPZ6438的血清白蛋白-壳聚糖纳米粒可通过诱导肿瘤细胞的凋亡来抑制骨肉瘤生长。 展开更多
关键词 牛血清白蛋白 壳聚糖 纳米粒 载药 骨肉瘤 细胞凋亡
下载PDF
The prognostic value of preoperative serum levels of CEA,CA19-9 and CA72-4 in patients with colorectal cancer 被引量:25
6
作者 Chao Xu Zheng~1 Wen Hua Zhan~1 Ji Zong Zhao~2 Dong Zheng~3 Dong Ping Wang~1 Yu Long He~1 Zhang Qing Zheng~1 ~1Department of General Surgery,~2Laboratory of Surgery,~3Department of Medicine,First Affiliated Hospital,Sun Yat-Sen University of Medical Sciences,Guangzhou 510080,Guangdong Province,ChinaDr.Chao Xu Zheng now working as a surgeon and lecturer in the Department of General Surgery,First Affiliated Hospital,Sun Yat-Sen University of Medical Sciences,who is a Ph.D.student,having 7 papers published. 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第3期431-434,共4页
INTRODUCTIONCarcinoembryonic antigen ( CEA) , originally described by Gold and Freedman [1] in 1965, is now an acknowledged member of immunoglobulin superfamily[2],with a role as an intracellular adhesion molecule[3].... INTRODUCTIONCarcinoembryonic antigen ( CEA) , originally described by Gold and Freedman [1] in 1965, is now an acknowledged member of immunoglobulin superfamily[2],with a role as an intracellular adhesion molecule[3].Carbohydrate antigen 19-9(CA19-9), obtained with a monoclonal antibody produced by immunizing a monoclonal antibody produced by immunizing a mouse with a colonic cancer cell line in 1979[4],is a ligand for E-selectin that plays an important role in the addhesion of cancer cells to endothelial cells [5,6]. 展开更多
关键词 tumor markers/biological COLORECTAL neoplasms/surgery COLORECTAL neoplasms/blood carcinoembryonic antigen/serum CA19-9 antigen/ serum antigens tumor-associated.carbohydrate/serum prognosis
下载PDF
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease 被引量:12
7
作者 erika utzeri paolo usai 《World Journal of Gastroenterology》 SCIE CAS 2017年第22期3954-3963,共10页
The use of non-steroidal anti-inflammatory drugs(NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of dige... The use of non-steroidal anti-inflammatory drugs(NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of digestive system complications in the course of their use. Recent data suggests that the complications of the lower gastro-intestinal tract may be as frequent and severe as those of the upper tract. NSAIDs enteropathy is due to enterohepatic recycling of the drugs resulting in a prolonged and repeated exposure of the intestinal mucosa to the compound and its metabolites. Thus leading to so-called topical effects, which, in turn, lead to an impairment of the intestinal barrier. This process determines bacterial translocation and toxic substances of intestinal origin in the portal circulation, leading to an endotoxaemia. This condition could determine a liver inflammatory response and might promote the development of nonalcoholic steatohepatitis, mostly in patients with risk factors such as obesity, metabolic syndrome and a high fat diet, which may induce a small intestinal bacterial overgrowth and dysbiosis. This alteration of gut microbiota may contribute to nonalcoholic fatty liver disease and its related disorders in two ways: firstly causing a malfunction of the tight junctions that play a critical role in the increase of intestinal permeability, and then secondly leading to the development of insulin resistance, body weight gain, lipogenesis, fibrogenesis and hepatic oxidative stress. 展开更多
关键词 Non-steroidal anti-inflammatory drugs Intestinal barrier Intestinal permeability Non-steroidal anti-inflammatory drugs - enteropathy Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis MICROBIOTA Metabolic syndrome Proton pump inhibitors ENDOTOXAEMIA
下载PDF
Comparisons of drug efficacy and time-effect among magnesium valproate,sustained-release magnesium valproate tablet and depakine chrono for epilepsy An experiment of determining cortical convulsive threshold in rats undergoing electrical stimulation
8
作者 Leiyu Geng Yuxi Liu Shurong Yan Jiali Xu 《Neural Regeneration Research》 SCIE CAS CSCD 2007年第12期732-735,共4页
BACKGROUND: Scholars have investigated the differences in drug metabolism and pharmacodynamics between valproate and its sustained-release tablets only from the angle of pharmaceutical sciences or clinical practice. ... BACKGROUND: Scholars have investigated the differences in drug metabolism and pharmacodynamics between valproate and its sustained-release tablets only from the angle of pharmaceutical sciences or clinical practice. Whether the fact that differences in drug efficacy and time-effect of different doses of valproate and different types of sustained-release valproate tablets at the same concentration can be quantitatively reflected by determining the changes in convulsive threshold pre- and post-administration in rat models of determining the convulsive threshold developed by direct cortical electrical stimulation remains unclear. OBJECTIVE: This study aimed to compare the drug efficacy and time-effect among magnesium valproate, sustained-release magnesium valproate tablet and depakine chrono in the treatment of epilepsy by determining the convulsive threshold of rat models created by direct cortical electrical stimulation, and human serum drug concentration before and after administration. DESIGN: A controlled observational experiment. SETTING: Research Institute of Epilepsy, Shanxi Medical University. MATERIALS: Adult health male SD rats of clean grade, weighing 200 - 220 g, provided by the Laboratory Animal Center of Shanxi Medical University. The protocol was carried out in accordance with requests from Animal Ethics Committees for guidance. Magnesium valproate (Lot No. 041004) and sustained-release magnesium valproate tablet (Lot No. 050501) were produced in Hunan Xiangzhong Pharmaceutical Co., Ltd. METHODS: This study was carried out in the Laboratory for Epilepsy, Shanxi Medical University between June and August 2005. (1)All the SD rats were created into models for determining cortical convulsive threshold. They were randomly divided into 4 groups with 20 rats in each: magnesium valproate tablet group, sustained-release magnesium valproate tablet group, depakine chrono group and control group. After being modeled, the rats in the first 3 groups were intragastrically administrated with magnesium valproate, sustained-release magnesium valproate tablet and depakine chrono, respectively, while the control group were intragastrically administrated with the same volume of normal saline. (2)Convulsive threshold of each fasting rat was determined 0.5 hour before, and 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14 and 24 hours after single administration, separately. (3) Convulsive threshold was determined repeatedly 2 weeks after single administration. Each rat was administrated two times daily successively. Convulsive threshold was determined 0.5 hour before, and 0.5, 2.5, 7 and 12 hours after administration, separately. (4)Hepatic and renal tissues were harvested for pathological examination after 1 month of administration. (5)Nine healthy voluntary medical stuffs were recruited in this study. Written informed consents of experiment were obtained each involved subject. The study was given an approval by the Ethics Committee of Shanxi Medical University. According to the scheme, the 9 volunteers were randomly assigned into 3 groups, in which, volunteers were asked to take magnesium valproate 500 g, sustained-release magnesium valproate tablet 500 g and depakine chrono 500 g, respectively, in the morning under the condition of fasting. Serum drug concentration of each drug was determined by fluorescence polarization immunoassay at different time points. MAIN OUTCOME MEASURES: (2) Rat convulsive threshold after single and repeated administrations. (2)Hepatic and renal pathological examination results. (3) Serum drug concentration in vivo. RESULTS:(4)Rat convulsive threshold after single and repeated administrations: Drug efficacy in the magnesium valproate tablet group reached to a peak level 1 to 2 hours after single administration, and was obviously higher than that in the other groups 1 hour after administration (P 〈 0.05). Drug efficacy in the sustained-release magnesium valproate tablet group and depakine chrono group both reached to a peak level 7 hours after administration, and was significantly higher than that in the control group (P 〈 0.05). After repeated administrations, the average peak valley deviation of the convulsive threshold in the magnesium valproate tablet group was 120- 150 μ A, which was 2 and 2.5 times as that in the sustained-release magnesium valproate tablet group and depakine chrono group, respectively. After repeated administrations for 10 times, convulsive threshold was increased by 440 μ A in the sustained-release magnesium valproate tablet group, and by 230 μ A in the depakine chrono group in comparison with before administration. (2) Hepatic and renal pathological examination results: No obvious differences in hepatic and renal impairment were found among the 4 groups after I month of administration successively. (3) Serum drug concentration in vivo: Serum-drug concentration of magnesium valproate was increased fast and reached to a peak level 0.5 - 2 hours after administration, remained at a relatively stable level 2 - 4 hours after administration, and then was slowly decreased. The drug efficacy of sustained-release magnesium valproate tablet and depakine chrono was slowly released 1 - 6 hours after administration, reached to a peak level at about 7 hours, and could last for about 16 hours. CONCLUSION: Magnesium valproate has a rapid onset and offset of action. Sustained-release magnesium valproate tablet has a slow onset but long duration of drug efficacy. Depakine chrono can be easier to be absorbed than sustained-release magnesium valproate tablet, but its long-term effect on improving the convulsive threshold is inferior to sustained-release magnesium valproate tablet. 展开更多
关键词 EPILEPSY valproate convulsive threshold serum drug concentration
下载PDF
Application of Thin Layer Chromatography in Preparation of Drug Containing Serum of Eucalyptus Oil
9
作者 Bingyang GUO Yongli YU +2 位作者 Shijuan LUO Xiaoqing YIN Mingzhen XU 《Medicinal Plant》 CAS 2018年第1期19-24,共6页
[Objectives] To explore whether the thin layer chromatography( TLC) can be used to guide the preparation of drug containing serum of eucalyptus oil. [Methods]Eucalyptus oil samples with different dilution ratio were d... [Objectives] To explore whether the thin layer chromatography( TLC) can be used to guide the preparation of drug containing serum of eucalyptus oil. [Methods]Eucalyptus oil samples with different dilution ratio were detected by TLC. Eucalyptus oil was intragastrically administered to mice,serum samples of different eucalyptus oil doses,different intragastric administration methods and different blood sampling times were collected. The above samples were detected by TLC,and the above results were verified by gas chromatography. [Results] TLC can detect concentration difference of eucalyptus oil samples with different dilution ratio. TLC can provide qualitative and semi-quantitative detection of eucalyptus oil in serum. High,medium and low dose of eucalyptus oil in serum had different effects on the growth of MCF-7 cells in the SD rats( P < 0. 05). [Conclusions] TLC can be used to guide the preparation of drug containing serum of eucalyptus oil. 展开更多
关键词 Chinese medicine drug containing serum Eucalyptus oil Thin layer chromatography
下载PDF
Chronic Alcohol Consumption Affects Serum Enzymes Levels in the HIV-Infected Patients on Stavudine (d4T)/Lamivudine (3TC)/Nevirapine (NVP) Treatment Regimen
10
作者 Godfrey S. Bbosa David B. Kyegombe +3 位作者 William W. Anokbonggo Aloysius Lubega Apollo Mugisha Jasper Ogwal-Okeng 《Pharmacology & Pharmacy》 2014年第2期181-194,共14页
Chronic alcohol use is a common problem globally among the HIV-infected patients on ARV treatment regimens, leading to severe liver damage and increase in serum enzymes. The study determined effect of chronic alcohol ... Chronic alcohol use is a common problem globally among the HIV-infected patients on ARV treatment regimens, leading to severe liver damage and increase in serum enzymes. The study determined effect of chronic alcohol intake on serum enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyl transferase (GGT)) in HIV-infected patients on d4T/3TC/NVP treatment regimen in Uganda using the WHO alcohol use disorders’ identification test (AUDIT) tool and chronic alcohol use biomarkers (ALT, AST, GGT, AST/ALT ≥ 2.0 and mean corpuscular volume (MCV)). A case control study using repeated measure design with serial measurements model was used. Alcohol use biomarkers were used to standardize the gender differences in alcohol use. A total of 41 patients (21 alcohol group and 20 control group) were followed up for 9 months with blood sampling done at 3 month intervals. The serum enzymes’ levels were determined by using the Cobas Intergra 400 Plus analyzer system. The mean GGT levels were higher in chronic alcohol use group as compared to control group in both groups. The levels were above reference ranges during 6 month and three times higher during 9-month follow-up period for both chronic alcohol use self reporting WHO AUDIT tool and biomarkers’ groups. Generally, the mean AST, ALT and AST/ALT levels were slightly higher in alcohol use group as compared to control group and were slightly higher in both groups as compared to reference ranges during the 9 month follow-up period. Chronic alcohol consumption by HIV-infected patients on d4T/3TC/NVP drug regimen increased GGT and AST/ALT serum enzyme levels and hence was used as chronic alcohol use biomarkers. 展开更多
关键词 CHRONIC Ethanol Use serum Enzymes HIV-INFECTED Patients ANTIRETROVIRAL (ARVs) drugs
下载PDF
The electrochemical behavior of N-n-undecy1-N'-(sodium-p- amino-benzenesulfonate) thiourea and its interaction with bovine serum albumin
11
作者 Hong Xia Luo Yang Du Zhi Xin Guo 《Chinese Chemical Letters》 SCIE CAS CSCD 2008年第5期581-584,共4页
In pH 5.5 phosphate buffer solution, N-n-undecyl-N'-(sodium-p-amino-benzenesulfonate) thiourea (UPT) produced a pair of redox peaks on the bare glassy carbon electrode. At the multi-walled carbon nanotube (MWNT... In pH 5.5 phosphate buffer solution, N-n-undecyl-N'-(sodium-p-amino-benzenesulfonate) thiourea (UPT) produced a pair of redox peaks on the bare glassy carbon electrode. At the multi-walled carbon nanotube (MWNT) modified electrode, the electrochemical behavior of UPT enhanced greatly. In the presence of bovine serum albumin (BSA), the peak currents of UPT decreased linearly due to the formation of a super-molecular complex. This method was successfully applied to the determination of BSA in a bovine serum sample. 展开更多
关键词 N-n-Undecyl-N'-(sodium-p-amino-benzenesulfonate) thiourea Carbon nanotube Electrocatalysis Bovine serum albumin
下载PDF
Elevated soluble 4-1BB is associated with serum markers of hepatitis B virus in patients with chronic hepatitis B
12
作者 Meng-Ru Zhan Xiu-Zhu Gao +4 位作者 Chang Wang Fei Peng Xiao-Mei Wang Hong-Qin Xu Jun-Qi Niu 《World Journal of Clinical Cases》 SCIE 2021年第7期1619-1630,共12页
BACKGROUND Previous studies have suggested that the costimulatory molecule 4-1BB plays pivotal roles in regulating immunity during chronic viral infection.However,up to now,there are few studies about 4-1BB in chronic... BACKGROUND Previous studies have suggested that the costimulatory molecule 4-1BB plays pivotal roles in regulating immunity during chronic viral infection.However,up to now,there are few studies about 4-1BB in chronic hepatitis B(CHB).AIM To clarify this issue,we report our comprehensive study results on the expression levels of 4-1BB in patients with CHB.METHODS From September 2018 to June 2019,a total of 64 patients with CHB were recruited from the Department of Hepatology,The First Hospital of Jilin University.Peripheral blood samples were collected from 52 treatment-naïve and 12 entecavir-treated patients with CHB as well as 37 healthy donors(including 24 healthy adults and 13 healthy children).The levels of soluble 4-1BB(s4-1BB)in plasma were measured by ELISA.4-1BB mRNA expression in peripheral blood mononuclear cells was detected by real-time quantitative PCR.RESULTS The s4-1BB levels in the plasma of patients with CHB were significantly higher than those in healthy adults(94.390±7.393 ng/mL vs 8.875±0.914 ng/mL,P<0.001).In addition,the s4-1BB level in plasma was significantly increased in patients with a higher viral load and a disease flare up.However,there were no significant differences between treatment-naïve and entecavir-treated patients.Interestingly,among treatment-naïve patients with CHB,the levels of s4-1BB in plasma had a significant positive correlation with hepatitis B surface antigen,hepatitis B virus DNA,hepatitis B e antigen,and triglyceride levels(r=0.748,P<0.001;r=0.406,P=0.004;r=0.356,P=0.019 and r=-0.469,P=0.007,respectively).The 4-1BB mRNA expression was higher in the peripheral blood mononuclear cells of patients with CHB than in the peripheral blood mononuclear cells of healthy adults,but the difference was not statistically significant.CONCLUSION These results suggest that the levels of s4-1BB may be associated with pathogenesis of hepatitis B virus and therefore may be a promising biomarker for disease progression. 展开更多
关键词 Hepatitis B virus Hepatitis B CHRONIC 4-1BB Soluble 4-1BB Hepatitis B virus serum marker
下载PDF
Investigation on the binding of (-)-epigallocatechin-3-O-gallate to bovine serum albumin by molecular spectroscopy
13
作者 WANG Jin ZHOU Jie +1 位作者 ZHU Shu-hua GAO Ji-gan 《Journal of Chemistry and Chemical Engineering》 2009年第1期27-35,共9页
The binding of (-)-epigallocatechin-3-O-gallate (EGCG) to bovine serum albumin (BSA) were investigated for the first time with spectral methods, including fluorescence and absorption spectrometry under simulativ... The binding of (-)-epigallocatechin-3-O-gallate (EGCG) to bovine serum albumin (BSA) were investigated for the first time with spectral methods, including fluorescence and absorption spectrometry under simulative physiological conditions. A strong fluorescence quenching reaction of EGCG to BSA was observed. It was proved that the fluorescence quenching of BSA by addition of EGCG was a result of the formation of EGCG-BSA complex. The binding constant K and the number of binding sites n were determined at physiological conditions and three different temperatures with fluorescence quenching method. The binding distance R and transfer efficiency E between BSA and EGCG were also obtained according to Forster theory of non-radiation energy transfer. The effects of Al^3+, Cu^2+, Mg^2+ and Fe^2+ on the binding constant between EGCG and BSA were studied at 298 K. The effect of EGCG on the conformation of BSA was also analyzed by synchronous fluorescence spectroscopy. PACS. 21. 10. Dr; 32. 50. +d; 32. 30. Jc; 82.80. Dx 展开更多
关键词 --epigallocatechin-3-O-gallate bovine serum albumin fluorescence quenching binding thermodynamics
下载PDF
Synthesis of (2S,4S)-2-Substituted-3- (3-Sulfanylpropanoyl)-6- Oxohexahydropyrimidine-4-Carboxylic Acids as Potential Antihypertensive Drugs
14
作者 Andrei Ershov Dmitry Nasledov +1 位作者 Igor Lagoda Valery Shamanin 《Journal of Materials Science and Chemical Engineering》 2015年第6期7-12,共6页
Proceeding from natural amino acid L-asparagine and commercially available aldehydes a stereoselective synthesis was developed of (2S,4S)-2-alkyl(aryl)-3-(3-sulfanylpropanoyl)-6-oxohexahy- dropyrimidine-4-carboxylic a... Proceeding from natural amino acid L-asparagine and commercially available aldehydes a stereoselective synthesis was developed of (2S,4S)-2-alkyl(aryl)-3-(3-sulfanylpropanoyl)-6-oxohexahy- dropyrimidine-4-carboxylic acids, potential antihypertensive drugs, inhibitors of the angiotensin converting enzyme. 展开更多
关键词 Synthesis of (2S 4S)-2-Substituted-3- (3-Sulfanylpropanoyl)-6- Oxohexahydropyrimidine-4-Carboxylic ACIDS AS POTENTIAL ANTIHYPERTENSIVE drugS
下载PDF
菊藻丸含药血清调控PTEN对乳腺癌MCF-7细胞生长和转移的作用研究
15
作者 欧阳志 王赫 欧阳慧婷 《中国医药导报》 CAS 2024年第9期1-8,共8页
目的 研究菊藻丸含药血清调控10号染色体上缺失的磷酸酶和张力蛋白同源物基因(PTEN)对人乳腺癌MCF-7细胞生长和转移的作用。方法 8周龄、体重(200±20)g的SPF级Wistar雌性大鼠12只,采用随机数字表法分为菊藻丸组和对照组,各6只。各... 目的 研究菊藻丸含药血清调控10号染色体上缺失的磷酸酶和张力蛋白同源物基因(PTEN)对人乳腺癌MCF-7细胞生长和转移的作用。方法 8周龄、体重(200±20)g的SPF级Wistar雌性大鼠12只,采用随机数字表法分为菊藻丸组和对照组,各6只。各组分别以5.4 g/(kg·d)菊藻丸和等量生理盐水灌胃,制备含药血清和空白对照血清。将培养好的人乳腺癌MCF-7细胞分为20%空白血清组、5%含药血清组、10%含药血清组、15%含药血清组和20%含药血清组,分别使用含20%空白对照血清和含5%、10%、15%、20%含药血清的培养基进行培养干预。采用CCK-8检测细胞增殖、集落形成实验观察克隆形成能力、TUNEL染色检测凋亡、流式细胞术检测周期分布、划痕实验和Transwell检测细胞迁移和侵袭能力,q PCR和Western blot检测PTEN m RNA和蛋白表达水平。结果 与20%空白血清组比较,10%、15%、20%含药血清组细胞增殖活性降低、克隆形成率减少、侵袭能力降低(P<0.05);5%、10%、15%、20%含药血清组细胞凋亡水平升高、迁移能力降低、细胞周期阻滞于G1期、PTEN的m RNA和蛋白表达水平均升高(P<0.05)。与5%含药血清组比较,10%、15%、20%含药血清组细胞增殖活性降低、克隆形成率降低、细胞凋亡水平升高、迁移能力降低、侵袭能力降低、细胞周期阻滞于G1期、PTEN m RNA和蛋白表达水平均升高(P<0.05)。结论 菊藻丸含药血清能抑制MCF-7细胞生长和转移,其机制可能与激活PTEN的表达有关。 展开更多
关键词 乳腺癌细胞 菊藻丸 磷酸酶和张力蛋白同源物 含药血清 MCF-7细胞
下载PDF
资癸益冲方通过调控SIRT1/PGC-1α信号通路对卵巢颗粒细胞线粒体能量代谢的改善作用
16
作者 刘雪平 唐思玲 +5 位作者 宿滋 李荣霞 郗红燕 张新苗 吴忠玉 段彦苍 《中成药》 CAS CSCD 北大核心 2024年第10期3271-3277,共7页
目的探讨资癸益冲方对早发性卵巢功能不全(POI)体外模型线粒体能量代谢的影响。方法应用丙烯醛(ACR)干预人卵巢颗粒细胞KGN构建POI体外模型,给予资癸益冲方含药血清干预,设置对照组、ACR组、资癸益冲方组、EX527(SIRT1抑制剂)组、EX527... 目的探讨资癸益冲方对早发性卵巢功能不全(POI)体外模型线粒体能量代谢的影响。方法应用丙烯醛(ACR)干预人卵巢颗粒细胞KGN构建POI体外模型,给予资癸益冲方含药血清干预,设置对照组、ACR组、资癸益冲方组、EX527(SIRT1抑制剂)组、EX527+资癸益冲方组。流式细胞术检测细胞凋亡率,DCFH-DA法检测细胞ROS水平,Mito-Trakine荧光标记法检测细胞线粒体数量,Seahorse法检测细胞线粒体氧化磷酸化水平,比色法检测细胞ATP水平,RT-qPCR法检测细胞mtDNA拷贝数和SIRT1、PGC-1α、Nrf1、TFAM mRNA表达,Western blot法检测细胞SIRT1、PGC-1α、Ac-PGC-1α、Nrf1、TFAM蛋白表达。结果与对照组比较,ACR组KGN细胞凋亡率和ROS水平升高(P<0.05,P<0.01),线粒体数量和mtDNA拷贝数减少(P<0.01),线粒体有氧呼吸基础值、呼吸最大值、储备值和ATP水平降低(P<0.05,P<0.01),SIRT1、PGC-1α、Nrf1、TFAM mRNA及蛋白表达降低(P<0.05,P<0.01),Ac-PGC-1α蛋白表达升高(P<0.01);与ACR组比较,资癸益冲方组以上指标均改善(P<0.05,P<0.01)。资癸益冲方与EX527联用后,逆转了前者对KGN细胞的上述作用(P<0.05,P<0.01)。结论资癸益冲方可能通过激活SIRT1/PGC-1α信号通路增加线粒体生物合成,改善ACR诱导的KGN细胞线粒体能量代谢障碍。 展开更多
关键词 资癸益冲方 含药血清 卵巢颗粒细胞 线粒体生物合成 线粒体能量代谢 SIRT1/PGC-1α信号通路
下载PDF
UPLC-MS/MS法测定人血清中曲唑酮浓度及其临床个体化用药
17
作者 曹银 周旋 +5 位作者 戴彪 邓逸芸 闫春宇 单锋 夏清荣 梁俊 《中国药物警戒》 2024年第9期991-997,共7页
目的 建立超高效液相串联质谱法(UPLC-MS/MS)测定患者血清中曲唑酮浓度,并用于曲唑酮的临床个体化用药。方法 色谱柱为MSCB-2A(2.1 mm×50 mm,2.5μm);流动相为甲醇(B)-水(A,含0.01%氨水),梯度洗脱(梯度设置为0~0.2 min,55%B;0.2~2.... 目的 建立超高效液相串联质谱法(UPLC-MS/MS)测定患者血清中曲唑酮浓度,并用于曲唑酮的临床个体化用药。方法 色谱柱为MSCB-2A(2.1 mm×50 mm,2.5μm);流动相为甲醇(B)-水(A,含0.01%氨水),梯度洗脱(梯度设置为0~0.2 min,55%B;0.2~2.0 min,55%~95%B;2.0~2.5 min,95%~95%B;2.5~2.6 min,95%~55%B;2.6~3.0 min,55%~55%B),流速0.5 m L·min^(-1),柱温40℃,进样量0.1μL;离子源:电喷雾离子源;电离模式:正离子模式。血清经乙腈沉淀蛋白,地西泮为内标,对本方法的专属性、标准曲线和定量下限、精密度与回收率、基质效应和稳定性进行相应的考察。同时将该方法应用于16例使用曲唑酮患者的血药浓度测定,并对检测结果进行分析,给出相应的干预意见。结果 血清中曲唑酮在10.0~1 500.0 ng·m L^(-1)内线性关系良好(R2=0.999 4);低、中、高3组不同质控浓度(50.0、400.0、1 000.0 ng·m L^(-1))日内和日间精密度的相对标准偏差(RSD)均小于7%,准确度为91.90%~98.67%;低、中、高浓度的曲唑酮血清在常温下4 h、2~8℃冰箱冷藏24 h、长期冷冻3个月以及反复冻融循环条件下稳定性良好,在各条件下准确度为95.04%~105.78%。该法已成功应用于曲唑酮临床样本治疗药物监测。结论 UPLC-MS/MS法检测曲唑酮血药浓度具有快速简便、稳定准确、灵敏度高、污染小等优点,该法可应用于曲唑酮临床个体化用药。 展开更多
关键词 曲唑酮 UPLC-MS/MS 治疗药物监测 血药浓度 人血清 个体化用药
下载PDF
The combined detection of carcinoembryonic antigen,carcinogenic antigen 125,and carcinogenic antigen 19-9 in colorectal cancer patients
18
作者 Ling-Zhen Gong Qian-Wen Wang Jie-Wen Zhu 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第7期2073-2079,共7页
BACKGROUND Hepatic metastases are common and difficult to treat after colorectal cancer(CRC)surgery.The predictive value of carcinoembryonic antigen(CEA),cancer antigen(CA)125 and CA19-9 combined tests for liver metas... BACKGROUND Hepatic metastases are common and difficult to treat after colorectal cancer(CRC)surgery.The predictive value of carcinoembryonic antigen(CEA),cancer antigen(CA)125 and CA19-9 combined tests for liver metastasis is unclear.AIM To evaluate predictive value of combined tests for CEA,CA125,and CA19-9 levels in patients with liver metastases of CRC.METHODS The retrospective study included patients with CRC alone(50 cases)and patients with CRC combined with liver metastases(50 cases)who were hospitalized between January 2021 and January 2023.Serum CEA,CA125 and CA19-9 levels were compared between the two groups,and binary logistic regression was used to analyze the predictive value of the combination of these tumor markers in liver metastasis.In addition,we performed receiver operating characteristic(ROC)curve analysis to assess its diagnostic accuracy.RESULTS The results showed that the serum CEA,CA125 and CA19-9 levels in the CRC with liver metastasis group were significantly higher than those in the CRC alone group.Specifically,the average serum CEA level in the CRC with liver metastasis group was 162.03±810.01 ng/mL,while that in the CRC alone group was 5.71±9.76 ng/mL;the average serum CA125 levels were 43.47±83.52 U/mL respectively.and 13.5±19.68 U/mL;the average serum CA19-9 levels were 184.46±473.13 U/mL and 26.55±43.96 U/mL respectively.In addition,binary logistic regression analysis showed that CA125 was significant in predicting CRC liver metastasis(P<0.05).ROC curve analysis results showed that the areas under the ROC curves of CEA,CA125 and CA19-9 were 0.607,0.692 and 0.586.CONCLUSION These results suggest that combined detection of these tumor markers may help early detection and intervention of CRC liver metastasis,thereby improving patient prognosis. 展开更多
关键词 Colorectal cancer Liver metastasis serum markers Carcinoembryonic antigen Cancer antigen 125 Cancer antigen 19-9 Receiver operating characteristic analysis
下载PDF
Association of KRAS Gene and microRNA-124-3p in Sporadic Colorectal Tumours
19
作者 Ozkan Bagci 《Journal of Biosciences and Medicines》 2024年第1期150-161,共12页
Aim: To reveal the exonic and 3’UTR sequences of KRAS, TP53, APC, BRAF, PIK3CA genes in sporadic colorectal tumors and to investigate the clinical relevance of 3’UTR variations in miRNA profiles. Methods: In the stu... Aim: To reveal the exonic and 3’UTR sequences of KRAS, TP53, APC, BRAF, PIK3CA genes in sporadic colorectal tumors and to investigate the clinical relevance of 3’UTR variations in miRNA profiles. Methods: In the study, the exonic and 3’UTR sequences of five genes in 12 sporadic colorectal tumors were extracted by next generation sequencing. In tumors with variation in the 3’UTR region, the changes caused by the variation in the miRNA binding profile were detected. The expression profile of these miRNAs in colorectal and other solid tumors compared to normal tissue was determined. Pathway analysis was performed to determine which signaling pathways miRNAs affect. Results: Case-10 in our study was wild type KRAS and received cetuximab treatment and developed drug resistance. In this case, it was concluded that the expression of KRAS increased and tumorigenesis progressed due to miRNAs that do not bind to this region due to variations in the 3’UTR region. Among these miRNAs, hsa-miR-124-3p was found to have decreased expression in colorectal tumors and to be associated with the ECM-receptor interaction pathway. Conclusion: Variations in the 3’UTR regions of genes critical in the process of carsinogenesis are associated with drug resistance and the process of tumorigenesis. 展开更多
关键词 Colorectal Tumours drug Resistance Personalised Medicine microRNA-124-3p
下载PDF
HPLC法快速测定5-氟尿嘧啶血药浓度 被引量:17
20
作者 刘传华 刘师莲 +3 位作者 卞继峰 耿昭 卢翌 胡海燕 《药物分析杂志》 CAS CSCD 北大核心 2001年第2期95-97,共3页
目的 :建立反相高效液相色谱法测定人血清中 5 -氟尿嘧啶浓度。方法 :血清样品用乙酸乙酯提取 ,水浴氮气吹干 ,残留物用水溶解后进样。色谱柱为C1 8柱 (2 5 0mm× 4 6mm) ,水为流动相 ,流速 1 0mL·min- 1 ,紫外检测波长 2 73n... 目的 :建立反相高效液相色谱法测定人血清中 5 -氟尿嘧啶浓度。方法 :血清样品用乙酸乙酯提取 ,水浴氮气吹干 ,残留物用水溶解后进样。色谱柱为C1 8柱 (2 5 0mm× 4 6mm) ,水为流动相 ,流速 1 0mL·min- 1 ,紫外检测波长 2 73nm ,桂皮酸为内标。结果 :本法最低检测浓度为 0 0 5 μg·mL- 1 ,线性范围为 1 0~ 5 0 0 μg·mL- 1 ,日内RSD为 2 7%~ 4 1% ,日间RSD为 3 8%~ 4 7(n =4)。结论 :该法适用于 5 -氟尿嘧啶的药代动力学研究及临床血药浓度检测。试验结果表明 ,该方法经济、简便、快速、灵敏度高、重现性好。 展开更多
关键词 高效液相色谱 5-氟尿嘧啶 血药浓度 药代动力学
下载PDF
上一页 1 2 71 下一页 到第
使用帮助 返回顶部